Companion focus Virbac derives the majority of its sales from companion animals (61%), indicating a strong channel and product lineup for pet owners. Sales opportunities exist in preventive care, diagnostics, and nutrition products tailored for households and clinics serving companion animals.

Global reach With production in 12 countries, sales subsidiaries in 36, and R&D on five continents, Virbac presents wide geographic footprints. Opportunities include entering or expanding in underpenetrated markets, leveraging local partnerships, and offering region-specific formulations.

Digital nudge The tech stack includes tools like SAS, Tableau, and Apache Airflow, suggesting data-driven marketing, forecasting, and operations. Potential upsell in data analytics services, demand forecasting collaborations, and digital advertising optimization for veterinary channels.

Growth momentum Strong Q1 2026 growth (+7.7% at constant rates) and 2025 revenue up 7.9% with solid EBIT margin indicate healthy financial health and scalable growth, presenting opportunities to propose value-based partnerships, co-marketing, and expanded product lines.

Platform leverage Priority Supercharge4 platforms drove double-digit growth in Q1 2026. This signals potential cross-sell opportunities to clinics and distributors for integrated platforms, including diagnostics, care, and nutrition solutions that complement core offerings.